| Dec 9, 2025 |
Dec 11, 2025 |
BioAge Labs, Inc.
|
Chief Medical Officer |
Sell |
10.0
|
-18,000
|
-100.00%
|
✓
|
$216K |
| Dec 4, 2025 |
Dec 5, 2025 |
BioAge Labs, Inc.
|
Chief Medical Officer |
Sell |
7.5
|
-68,897
|
-100.00%
|
✓
|
$701.9K |
| Mar 18, 2016 |
Mar 22, 2016 |
XOMA Royalty Corp
|
Sr. VP Clinical Dev. & CMO |
Sell |
26.3
|
-24,194
|
-6.64%
|
✗
|
$19K |
| Mar 31, 2015 |
Feb 16, 2016 |
XOMA Royalty Corp
|
Sr. VP Clinical Dev. & CMO |
Buy |
83.8
|
+8,573
|
3.43%
|
✗
|
$16.2K |
| Aug 14, 2015 |
Aug 18, 2015 |
XOMA Royalty Corp
|
Sr. VP Clinical Dev. & CMO |
Sell |
27.5
|
-10,801
|
-6.92%
|
✗
|
$9K |
| Jul 15, 2015 |
Jul 17, 2015 |
XOMA Royalty Corp
|
Sr. VP Clinical Dev. & CMO |
Sell |
41.3
|
-5,000
|
-3.73%
|
✓
|
$23K |
| Jul 9, 2015 |
Jul 10, 2015 |
XOMA Royalty Corp
|
Sr. VP Clinical Dev. & CMO |
Sell |
25.0
|
-33,400
|
-11.72%
|
✓
|
$152K |
| May 28, 2015 |
Jun 1, 2015 |
XOMA Royalty Corp
|
Sr. VP Clinical Dev. & CMO |
Sell |
27.5
|
-1,788
|
-1.36%
|
✗
|
$6.4K |
| Mar 23, 2015 |
Mar 23, 2015 |
XOMA Royalty Corp
|
Sr. VP Clinical Dev. & CMO |
Sell |
15.0
|
-32,742
|
-20.58%
|
✓
|
$128.9K |
| Mar 18, 2015 |
Mar 20, 2015 |
XOMA Royalty Corp
|
Sr. VP Clinical Dev. & CMO |
Sell |
22.5
|
-20,535
|
-11.43%
|
✗
|
$82.4K |
| Dec 31, 2013 |
Feb 17, 2015 |
XOMA Royalty Corp
|
Sr. VP Clinical Dev. & CMO |
Buy |
78.8
|
+4,579
|
1.37%
|
✗
|
$19.7K |
| Dec 15, 2014 |
Dec 16, 2014 |
XOMA Royalty Corp
|
Sr. VP Clinical Dev. & CMO |
Sell |
46.3
|
-1,600
|
-2.03%
|
✓
|
$7.4K |
| Nov 20, 2014 |
Nov 21, 2014 |
XOMA Royalty Corp
|
Sr. VP Clinical Dev. & CMO |
Sell |
36.3
|
-5,000
|
-6.07%
|
✓
|
$22.8K |
| Oct 28, 2014 |
Oct 29, 2014 |
XOMA Royalty Corp
|
Sr. VP Clinical Dev. & CMO |
Sell |
36.3
|
-5,000
|
-6.07%
|
✓
|
$22.8K |
| Sep 15, 2014 |
Sep 16, 2014 |
XOMA Royalty Corp
|
Sr. VP Clinical Dev. & CMO |
Sell |
36.3
|
-5,000
|
-6.07%
|
✓
|
$22.9K |
| Sep 4, 2014 |
Sep 8, 2014 |
XOMA Royalty Corp
|
Sr. VP Clinical Dev. & CMO |
Sell |
28.8
|
-10,000
|
-11.45%
|
✓
|
$45.6K |
| Aug 14, 2014 |
Aug 19, 2014 |
XOMA Royalty Corp
|
Sr. VP Clinical Dev. & CMO |
Sell |
10.0
|
-26,748
|
-25.70%
|
✓
|
$116.1K |
| Jun 16, 2014 |
Jun 18, 2014 |
XOMA Royalty Corp
|
Sr. VP Clinical Dev. & CMO |
Sell |
25.0
|
-11,580
|
-13.02%
|
✓
|
$52.6K |
| May 28, 2014 |
May 29, 2014 |
XOMA Royalty Corp
|
Sr. VP Clinical Dev. & CMO |
Sell |
27.5
|
-1,785
|
-1.97%
|
✗
|
$7.5K |
| May 13, 2014 |
May 15, 2014 |
XOMA Royalty Corp
|
Sr. VP Clinical Dev. & CMO |
Sell |
26.3
|
-10,000
|
-10.41%
|
✗
|
$38.4K |
| Mar 18, 2014 |
Mar 20, 2014 |
XOMA Royalty Corp
|
Sr. VP Clinical Dev. & CMO |
Sell |
32.5
|
-17,649
|
-6.22%
|
✓
|
$111.4K |
| Feb 18, 2014 |
Feb 19, 2014 |
XOMA Royalty Corp
|
Sr. VP Clinical Dev. & CMO |
Sell |
13.8
|
-6,000
|
-41.27%
|
✓
|
$45.3K |
| Dec 31, 2013 |
Feb 14, 2014 |
XOMA Royalty Corp
|
Sr. VP Clinical Dev. & CMO |
Buy |
90.0
|
+888
|
11.16%
|
✗
|
$5.9K |
| Jan 21, 2014 |
Jan 23, 2014 |
XOMA Royalty Corp
|
Sr. VP Clinical Dev. & CMO |
Sell |
13.8
|
-6,000
|
-35.55%
|
✓
|
$49.6K |
| Dec 18, 2013 |
Dec 18, 2013 |
XOMA Royalty Corp
|
Sr. VP Clinical Dev. & CMO |
Sell |
13.8
|
-6,000
|
-42.99%
|
✓
|
$34K |
| Nov 27, 2013 |
Dec 2, 2013 |
XOMA Royalty Corp
|
Sr. VP Clinical Dev. & CMO |
Sell |
13.8
|
-4,696
|
-37.12%
|
✓
|
$21.3K |
| Nov 18, 2013 |
Nov 19, 2013 |
XOMA Royalty Corp
|
Sr. VP Clinical Dev. & CMO |
Sell |
30.0
|
-1,304
|
-14.08%
|
✓
|
$5.3K |
| Oct 18, 2013 |
Nov 1, 2013 |
XOMA Royalty Corp
|
Sr. VP Clinical Dev. & CMO |
Sell |
13.8
|
-5,254
|
-59.79%
|
✓
|
$24.7K |
| Oct 18, 2013 |
Oct 21, 2013 |
XOMA Royalty Corp
|
Sr. VP Clinical Dev. & CMO |
Sell |
37.5
|
-746
|
-5.35%
|
✓
|
$3.5K |
| Sep 30, 2013 |
Oct 2, 2013 |
XOMA Royalty Corp
|
Sr. VP Clinical Dev. & CMO |
Buy |
82.5
|
+459
|
3.60%
|
✗
|
$2K |
| Sep 18, 2013 |
Sep 19, 2013 |
XOMA Royalty Corp
|
Sr. VP Clinical Dev. & CMO |
Sell |
13.8
|
-6,000
|
-32.00%
|
✓
|
$27.2K |
| Aug 19, 2013 |
Aug 19, 2013 |
XOMA Royalty Corp
|
Sr. VP Clinical Dev. & CMO |
Sell |
18.8
|
-6,000
|
-24.24%
|
✓
|
$22.4K |
| Aug 14, 2013 |
Aug 16, 2013 |
XOMA Royalty Corp
|
Sr. VP Clinical Dev. & CMO |
Sell |
26.3
|
-10,520
|
-29.83%
|
✗
|
$40.6K |
| Jul 18, 2013 |
Jul 19, 2013 |
XOMA Royalty Corp
|
Sr. VP Clinical Dev. & CMO |
Sell |
13.8
|
-6,000
|
-32.22%
|
✓
|
$28.2K |
| May 28, 2013 |
May 29, 2013 |
XOMA Royalty Corp
|
Sr. VP Clinical Dev. & CMO |
Sell |
27.5
|
-1,797
|
-14.24%
|
✗
|
$7.5K |
| May 20, 2013 |
May 21, 2013 |
XOMA Royalty Corp
|
Sr. VP Clinical Dev. & CMO |
Sell |
15.0
|
-6,000
|
-42.99%
|
✓
|
$3.3K |
| Mar 18, 2013 |
Mar 27, 2013 |
XOMA Royalty Corp
|
Sr. VP Clinical Dev. & CMO |
Sell |
46.3
|
-6,990
|
-28.34%
|
✗
|
$23K |
| Dec 31, 2012 |
Feb 13, 2013 |
XOMA Royalty Corp
|
Sr. VP Clinical Dev. & CMO |
Buy |
90.0
|
+2,214
|
52.17%
|
✗
|
$5.6K |
| Dec 30, 2011 |
Feb 14, 2012 |
XOMA Royalty Corp
|
VP Clinical Dev. & CMO |
Buy |
90.0
|
+3,844
|
376.13%
|
✗
|
$4.3K |